JAKUB TOLAR to Dyskeratosis Congenita
This is a "connection" page, showing publications JAKUB TOLAR has written about Dyskeratosis Congenita.
Connection Strength
0.515
-
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation. Transplant Cell Ther. 2024 10; 30(10):1005.e1-1005.e17.
Score: 0.213
-
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita. Br J Haematol. 2018 10; 183(1):110-118.
Score: 0.141
-
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. Biol Blood Marrow Transplant. 2017 Sep; 23(9):1422-1428.
Score: 0.130
-
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017 May; 23(5):726-735.
Score: 0.032